Table 2. Antiviral therapy for the patients.

Antiviral therapy (n = 70) a	Before enrollment	After enrollment b
Lamivudine	6 (8.6%)	/
Adefovir Dipivoxil	1 (1.4%)	/
Lamivudine plus Adefovir Dipivoxil	8 (11.4%)	/
Entecavir	15 (21.4%)	40 (57.1%)
Total	30 (42.9%)	40 (57.1%)

Data were present as number (%)

a Two patients refused to receive antiviral therapy.

b Antiviral therapy was applied in patients within 72 hours after enrollment.